Market Cap 3.04B
Revenue (ttm) 560.23M
Net Income (ttm) -569.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -101.60%
Debt to Equity Ratio 0.00
Volume 937,300
Avg Vol 2,164,548
Day's Range N/A - N/A
Shares Out 96.37M
Stochastic %K 65%
Beta 0.21
Analysts Strong Sell
Price Target $85.85

Company Profile

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevi...

Industry: Biotechnology
Sector: Healthcare
Phone: 415 483 8800
Address:
60 Leveroni Court, Novato, United States
ZacksResearch
ZacksResearch Sep. 9 at 3:57 PM
$RARE's gene therapy shows promise, but can it reverse the stock's decline? RARE posted strong long-term data for its DTX401 therapy, reducing cornstarch intake by 61% in GSDIa patients and enhancing quality of life. Despite this, shares are down 25.1% YTD, underperforming the industry's 4.5% growth. Full analysis here 👉 https://www.zacks.com/stock/news/2748856/rare-reports-positive-long-term-data-from-metabolic-disorder-study?cid=sm-stocktwits-2-2748856-body-11583&ADID=SYND_STOCKTWITS_TWEET_2_2748856_BODY_11583
0 · Reply
ZacksResearch
ZacksResearch Sep. 9 at 2:57 PM
$RARE long-term win? Ultragenyx’s 96-week data shows DTX401 slashed cornstarch requirements and boosted quality of life for GSDIa patients. Full study impact here 👉 https://www.zacks.com/stock/news/2748856/rare-reports-positive-long-term-data-from-metabolic-disorder-study?cid=sm-stocktwits-2-2748856-teaser-11542&ADID=SYND_STOCKTWITS_TWEET_2_2748856_TEASER_11542
0 · Reply
JarvisFlow
JarvisFlow Sep. 9 at 10:30 AM
HC Wainwright & Co. updates rating for Ultragenyx Pharmaceutical ( $RARE ) to Buy, target set at 80.
0 · Reply
Airbags
Airbags Sep. 5 at 4:35 PM
$TNXP I don't feel silly. I just made a total return of 30% on $FBIO, and some on $RARE. I would have just kept bleeding at TNXP. This is an amazing drug with crazy potential, but the lack of communication is a killer, and volume/ $ change is 💩
1 · Reply
Masonsy
Masonsy Sep. 4 at 4:57 PM
$RARE hope great info/updates will be shared on the investor conference today.
1 · Reply
KWalzz
KWalzz Sep. 3 at 6:50 AM
$RARE what a gem in bio world. this will go up sharply in the near term.
0 · Reply
RenaissanceTrading
RenaissanceTrading Sep. 2 at 6:55 PM
0 · Reply
Bovan
Bovan Sep. 2 at 6:44 PM
$RARE what’s the news for the 5% increase
0 · Reply
LQQKER_INSIDER
LQQKER_INSIDER Sep. 2 at 5:30 PM
$RARE On it's way! 💋 💋 💋 💋 💋 💋 💋
1 · Reply
hockeysniper
hockeysniper Aug. 30 at 9:42 PM
$RARE a california politician bought recently, gonna be on watch
0 · Reply
Latest News on RARE
Ultragenyx to Participate at Investor Conferences in September

Aug 29, 2025, 4:30 PM EDT - 11 days ago

Ultragenyx to Participate at Investor Conferences in September


Ultragenyx: Commercial Engine Fuels Rare Disease Pipeline

Apr 16, 2025, 9:49 AM EDT - 5 months ago

Ultragenyx: Commercial Engine Fuels Rare Disease Pipeline


Ultragenyx to Participate at Investor Conferences in March

Feb 24, 2025, 4:30 PM EST - 7 months ago

Ultragenyx to Participate at Investor Conferences in March


Ultragenyx to Participate in Investor Conferences in December

Nov 26, 2024, 4:30 PM EST - 10 months ago

Ultragenyx to Participate in Investor Conferences in December


Ultragenyx: Ready For More Growth After Q3 Earnings Beat

Nov 12, 2024, 11:12 AM EST - 10 months ago

Ultragenyx: Ready For More Growth After Q3 Earnings Beat


ZacksResearch
ZacksResearch Sep. 9 at 3:57 PM
$RARE's gene therapy shows promise, but can it reverse the stock's decline? RARE posted strong long-term data for its DTX401 therapy, reducing cornstarch intake by 61% in GSDIa patients and enhancing quality of life. Despite this, shares are down 25.1% YTD, underperforming the industry's 4.5% growth. Full analysis here 👉 https://www.zacks.com/stock/news/2748856/rare-reports-positive-long-term-data-from-metabolic-disorder-study?cid=sm-stocktwits-2-2748856-body-11583&ADID=SYND_STOCKTWITS_TWEET_2_2748856_BODY_11583
0 · Reply
ZacksResearch
ZacksResearch Sep. 9 at 2:57 PM
$RARE long-term win? Ultragenyx’s 96-week data shows DTX401 slashed cornstarch requirements and boosted quality of life for GSDIa patients. Full study impact here 👉 https://www.zacks.com/stock/news/2748856/rare-reports-positive-long-term-data-from-metabolic-disorder-study?cid=sm-stocktwits-2-2748856-teaser-11542&ADID=SYND_STOCKTWITS_TWEET_2_2748856_TEASER_11542
0 · Reply
JarvisFlow
JarvisFlow Sep. 9 at 10:30 AM
HC Wainwright & Co. updates rating for Ultragenyx Pharmaceutical ( $RARE ) to Buy, target set at 80.
0 · Reply
Airbags
Airbags Sep. 5 at 4:35 PM
$TNXP I don't feel silly. I just made a total return of 30% on $FBIO, and some on $RARE. I would have just kept bleeding at TNXP. This is an amazing drug with crazy potential, but the lack of communication is a killer, and volume/ $ change is 💩
1 · Reply
Masonsy
Masonsy Sep. 4 at 4:57 PM
$RARE hope great info/updates will be shared on the investor conference today.
1 · Reply
KWalzz
KWalzz Sep. 3 at 6:50 AM
$RARE what a gem in bio world. this will go up sharply in the near term.
0 · Reply
RenaissanceTrading
RenaissanceTrading Sep. 2 at 6:55 PM
0 · Reply
Bovan
Bovan Sep. 2 at 6:44 PM
$RARE what’s the news for the 5% increase
0 · Reply
LQQKER_INSIDER
LQQKER_INSIDER Sep. 2 at 5:30 PM
$RARE On it's way! 💋 💋 💋 💋 💋 💋 💋
1 · Reply
hockeysniper
hockeysniper Aug. 30 at 9:42 PM
$RARE a california politician bought recently, gonna be on watch
0 · Reply
LQQKER_INSIDER
LQQKER_INSIDER Aug. 28 at 1:46 AM
$RARE ❤️🤍💙
0 · Reply
CattleFarmerJ
CattleFarmerJ Aug. 25 at 1:02 AM
$RARE About to open a position in this tomorrow long term it looks great with it only 4 dollars from atl
0 · Reply
LQQKER_INSIDER
LQQKER_INSIDER Aug. 23 at 3:08 AM
0 · Reply
FelixH86
FelixH86 Aug. 22 at 4:24 PM
$RARE added..
0 · Reply
Airbags
Airbags Aug. 22 at 3:22 PM
$TNXP $FBIO $RARE.. so strange. Between 10:15 and 10:30 all 3 of these biotech tickers sank big time!!
0 · Reply
Airbags
Airbags Aug. 22 at 1:09 PM
$RARE can someone explain why this is bearish when there is an upcoming PDUFA?
0 · Reply
Bio_Invest101
Bio_Invest101 Aug. 19 at 4:55 PM
$RARE VP is not changed and maybe pharmaceutical lobbyists and community advocates need to work harder https://www.fiercebiotech.com/biotech/ptc-therapeutics-friedreichs-ataxia-hopes-derailed-crl-fda
0 · Reply
360sage
360sage Aug. 19 at 1:30 AM
$RARE When double
0 · Reply
Bio_Invest101
Bio_Invest101 Aug. 16 at 1:09 PM
$ARWR VP is a changed man, to some degree ? $RARE
0 · Reply
commanche
commanche Aug. 14 at 8:38 AM
$RARE lets get back to 30 today
1 · Reply
justiceforb_85
justiceforb_85 Aug. 14 at 3:51 AM
$RARE why is this doing so poorly? They have an anticipated BLA submission later this year and are currently generating revenue (I know, not profitable yet, but as are most biotechs).
0 · Reply
LQQKER_INSIDER
LQQKER_INSIDER Aug. 13 at 8:52 PM
$RARE MOON🌙 IT !!!
0 · Reply